Moderna Inc (MRNA)
Healthcare
Biotechnology
55.10 $
+0.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Moderna Inc (MRNA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 145 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,831 | 2,813 | 167 | 221 | 1,855 | 956 | 107 | 142 | 1,016 | 678 | 389 | 145 | 2,228 | |
| 2,241 | 929 | 96 | 115 | 514 | 739 | 90 | 119 | 1,008 | 452 | 955 | 93 | 2,508 | |
| -410 | 1,884 | 71 | 106 | 1,341 | 217 | 17 | 23 | 8.0 | 226 | -566 | 52 | -280 | |
| 1,160 | 1,406 | 1,027 | 1,221 | 1,137 | 1,122 | 856 | 700 | 801 | 775 | 649 | 651 | 2,876 | |
| 442 | 266 | 274 | 268 | 281 | 351 | 212 | 230 | 268 | 308 | 173 | – | – | |
| 1,602 | 1,878 | 1,337 | 1,469 | 1,411 | 1,463 | 1,067 | 930 | 268 | 1,083 | 822 | 867 | 3,040 | |
| -2,012 | 6.0 | -1,266 | -1,363 | -70 | -1,246 | -1,050 | -907 | -260 | -857 | -1,388 | -815 | -3,320 | |
| 10 | 6.0 | 6.0 | 6.0 | 6.0 | 6.0 | 1.0 | 1.0 | 0.0 | 8.0 | 17 | 17 | 42 | |
| -1,958 | 70 | -1,165 | -1,279 | 21 | -1,184 | -964 | -818 | -187 | -799 | -1,334 | -767 | -3,087 | |
| 1,672 | -147 | 10 | – | 8.0 | -64 | 7.0 | 7.0 | 13 | 27 | 9.0 | 15 | 64 | |
| -3,630 | 217 | -1,175 | -1,279 | 13 | -1,120 | -971 | -825 | -200 | -826 | -1,343 | -782 | -3,151 | |
| -1,699 | 278 | -1,123 | -1,232 | 79 | -1,118 | -924 | -760 | -135 | -732 | -1,258 | -815 | -2,940 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.